Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (6079)	10/15/1998 6:27:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Move Over Viagra; Chew On This! New Sex Gum Is An Aphrodisiac MEXICO, Posted 10:29 a.m. October 15, 1998 -- Move over Viagra, there's a new aphrodisiac in town. NewsChannel5 reports a Mexican manufacturer has found a way to combine damiamine, an herb used in Pre-Columbian times by the Mayan Indians, with natural chicle or gum to make what the companies calls a chewable aphrodisiac. The herb supposedly increases blood pressure and hormonal activity in women and men. The gum is currently being marketed in Canada and the United States. Manufacturers are not selling the gum in Latin America because, according to them, their people are so naturally passionate that they don't need the extra hand. Consumers say they plan to sell the gum in 80 countries within six months. The gum is to be chewed before bedtime. Compiled by NewsNet5 Staff newsnet5.com

To: Anthony Wong who wrote (6079)	10/15/1998 6:30:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

London Telegraph: America falls out of love with Viagra By David Sapsted in New York October 15, 1998 THE Viagra bubble appears to have burst only six months after the impotency drug created an unprecedented stampede in America. In its first three months on the market it became the fastest-selling drug ever at $411 million (£241.8 million). But sales are down to little more than a third of that in the past three months. Pfizer, the New York-based manufacturer that is currently marketing the pill in Europe, yesterday blamed the slump on "the high level of wholesaler stocking" and a reduction in prescriptions being written by doctors for the $10-a-time pill. The company has now embarked on its first, direct-to-consumer advertising campaign, including soft-focus television commercials of loving couples, to boost sales of the drug, which cures erectile dysfunction, believed to affect up to 30 million American males. Anecdotally, doctors attribute the sharp drop to a fall in demand from men who are not impotent but who rushed to get it, believing it could improve their sexual performance. One Connecticut GP said: "People started taking it for purely social reasons. Often, they took the pill in conjunction with alcohol and - surprise, surprise - decided it did not do anything for them. Or their partners." Viagra also received a bad press when the US Food and Drug Administration began an inquiry to see if the deaths of more than a dozen men who had taken part in the original Viagra trials were linked to the drug. None was found. telegraph.co.uk